baclofen has been researched along with Leukodystrophy, Metachromatic in 1 studies
Leukodystrophy, Metachromatic: An autosomal recessive metabolic disease caused by a deficiency of CEREBROSIDE-SULFATASE leading to intralysosomal accumulation of cerebroside sulfate (SULFOGLYCOSPHINGOLIPIDS) in the nervous system and other organs. Pathological features include diffuse demyelination, and metachromatically-staining granules in many cell types such as the GLIAL CELLS. There are several allelic and nonallelic forms with a variety of neurological symptoms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van der Veldt, N | 1 |
| van Rappard, DF | 1 |
| van de Pol, LA | 1 |
| van der Knaap, MS | 1 |
| van Ouwerkerk, WJR | 1 |
| Becher, JG | 1 |
| Wolf, NI | 1 |
| Buizer, AI | 1 |
1 other study available for baclofen and Leukodystrophy, Metachromatic
| Article | Year |
|---|---|
Intrathecal baclofen in metachromatic leukodystrophy.
Topics: Adolescent; Baclofen; Child; Female; Humans; Infusion Pumps, Implantable; Injections, Spinal; Leukod | 2019 |